miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression with potential in cancer diagnostics and therapeutics.
• MiR-137 is known to be underexpressed and involved in various cellular processes, but its specific role in gastric cancer (GC) remains largely unelucidated.

Purpose of the Study:

• To investigate the role and mechanism of microRNA-137 (miR-137) in gastric cancer (GC).
• To determine if miR-137 functions as a tumor suppressor in GC by targeting specific molecular pathways.

Main Methods:

• Quantitative real-time PCR to assess miR-137 expression levels in GC tissues.
• In vitro and in vivo experiments to evaluate the functional role of miR-137.
• Western blotting to analyze the expression of target proteins and signaling pathway components, including Cyclooxygenase-2 (Cox-2) and the PI3K/AKT pathway.

Main Results:

• MiR-137 was found to be significantly underexpressed in GC tissues compared to normal tissues.
• Overexpression of miR-137 demonstrated tumor-suppressive effects in GC cells, inhibiting proliferation and promoting apoptosis.
• MiR-137 directly targets Cyclooxygenase-2 (Cox-2), leading to the suppression of the PI3K/AKT signaling pathway.
• Restoring Cox-2 expression partially reversed the tumor-suppressive effects of miR-137 in GC cells.

Conclusions:

• MiR-137 acts as a tumor suppressor in gastric cancer.
• The tumor-suppressive function of miR-137 is mediated through the direct targeting of Cox-2 and subsequent inhibition of the PI3K/AKT signaling pathway.
• MiR-137 represents a potential therapeutic target for gastric cancer treatment.